The Role of Chemokines in Inflammatory Skin Diseases

  • G. Girolomoni
  • S. Pastore
  • A. Cavani
  • C. Albanesi
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 44)


The skin provides a major boundary between the host and the external environment, and it is obviously very well equipped to mount effective immune responses against microorganisms. Dendritic cells (DCs), including epidermal Langerhans cells and dermal DCs, specialize in recognizing and capturing foreign antigens as well as in the activation of naive T cells, and are thus essential for the induction of immune responses. T lymphocytes transduce antigen recognition into effector mechanisms to eliminate pathogens. The recruitment of T cells and other leukocytes at the site of skin inflammation is therefore a critical step for an efficient engagement of potentially dangerous signals (Koelle et al. 2002). The outcome of T cell-dependent skin reactions also depends on the cross-talk between infiltrating T cells and resident skin populations. Keratinocytes, mast cells, and endothelial cells, which constitute the static component of the skin immune system, as well as DCs contribute to attract discrete T cell subsets in the skin. In turn, activated T cells secrete cytokines and express molecules which activate resident cells, leading to amplification of the inflammatory reaction.


Atopic Dermatitis Chemokine Receptor Allergy Clin Immunol Allergic Contact Dermatitis Inflammatory Skin Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe M, Kondo T, Xu H, Fairchild RL (1996) Interferon-y inducible protein (IP-10) expression is mediated by CD8+ T cells and is regulated by CD4+ T cells during the elicitation phase of contact hypersensitivity. J Invest Dermatol 107: 360–366PubMedCrossRefGoogle Scholar
  2. Ajuebor MN, Hogaboam CM, Kunkel SL, Proudfoot AE, Wallace JL (2001) The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol 166: 552–558PubMedGoogle Scholar
  3. Albanesi C, Cavani A, Girolomoni G (1999) Interleukin-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes. Synergistic or antagonist effects with interferon-y and tumor necrosis factor-a. J Immunol 162: 494–502Google Scholar
  4. Albanesi C, Scarponi C, Federici M, Nasorri F, Cavani A, Girolomoni G (2000a) Interleukin 17 is produced by both Thl and Th2 lymphocytes, and modulates interferon-y-and interleukin 4-induced activation of human keratinocytes. J Invest Dermatol 115: 81–87PubMedCrossRefGoogle Scholar
  5. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, De Pità O, Puddu P, Girolomoni G (2000 b) IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J Immunol 165: 1395–1402Google Scholar
  6. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, Sozzani S, Girolomoni G (2001) A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Thl cell accumulation in chronic inflammatory skin diseases. J Leukoc Biol 70: 617–623PubMedGoogle Scholar
  7. Anttila HS, Reitamo S, Erkko P, Ceska M, Moser B, Baggiolini M (1992) Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol 98: 96–101PubMedCrossRefGoogle Scholar
  8. Asadullah K, Friedrich M, Hanneken S, Rohrbach C, Audring H, Vergopoulos A, Ebeling M, Docke WD, Volk HD, Sterry W (2001) Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings. J Invest Dermatol 116: 721–727PubMedCrossRefGoogle Scholar
  9. Asadullah K, Volk H-D, Sterry W (2002) Novel immunotherapies for psoriasis. Trends Immunol 23: 47–53PubMedCrossRefGoogle Scholar
  10. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640–644PubMedCrossRefGoogle Scholar
  11. Biedermann T, Kneilling M, Mailhammer R, Maier K, Sander CA, Kollias G, Kunkel SL, Hültner L, Röcken M (2000) Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 192: 1441–1451PubMedCrossRefGoogle Scholar
  12. Biedermann T, Mailhammer R, Mai A, Sander C, Ogilvie A, Brombacher F, Maier K, Levine AD, Röcken M (2001) Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells. Eur J Immunol 31: 1582–1591PubMedCrossRefGoogle Scholar
  13. Bodgan C (2001) Nitric oxide and the immune response. Nat Immunol 2: 907–916Google Scholar
  14. Bonecchi R, Bianchi G, Bordignon PP, D’Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Thl s) and Th2 s. J Exp Med 187: 129–134PubMedCrossRefGoogle Scholar
  15. Bouloc A, Cavani A, Katz SI (1998) Contact hypersensitivity in MHC class II-deficient mice depends on CD8+ T lymphocytes primed by immunostimulating Langerhans cells. J Invest Dermatol 111: 44–49PubMedCrossRefGoogle Scholar
  16. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L, Butcher EC (1999) The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776–780PubMedCrossRefGoogle Scholar
  17. Carter PH (2002) Chemokine receptor antagonism as a approach to anti-inflammatory therapy: “just right” or plain wrong? Curr Opin Chem Biol 6: 510–525PubMedCrossRefGoogle Scholar
  18. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G (2000) Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Thl immune responses. J Invest Dermatol 114: 295–302PubMedCrossRefGoogle Scholar
  19. Cavani A, Albanesi C, Traidl C, Sebastiani S, Girolomoni G (2001) Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 22: 118–120PubMedCrossRefGoogle Scholar
  20. Charbonnier A-S, Kohrgruber N, Kriehuber E, Stingl G, Rot A, Maurer D (1999) Macrophage inflammatory protein 3a is involved in the constitutive trafficking of epidermal Langerhans cells. J Exp Med 190: 1755–1767PubMedCrossRefGoogle Scholar
  21. Corinti S, Chiarantini L, Dominici S, Laguardia ME, Magnani M, Girolomoni G (2002) Erythrocytes deliver Tat to interferon-y-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro. J Leukoc Biol 71: 652–658PubMedGoogle Scholar
  22. Cruikshank WW, Kornfeld H, Center DM (2000) Interleukin-16. J Leukoc Biol 67: 757–766Google Scholar
  23. D’Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A, Sinigaglia F (1998) Selective upregulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 161: 5111–5115PubMedGoogle Scholar
  24. D’Ambrosio D, Albanesi A, Lang R, Girolomoni G, Sinigaglia F, Laudanna C (2002) Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion. J Immunol 169: 2303–2312PubMedGoogle Scholar
  25. Dieu-Nosejan M-C, Massacrier C, Homey B, Vanbervliet B, Pin J-J, Vicari A, Lebecque S, Dezutter-Dambuyant C, Schmitt D, Zlotnik A, Caux C (2000) Macrophage inflammatory protein 3a is expressed at inflamed epithelial cell surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 192: 705–717CrossRefGoogle Scholar
  26. Dulkys Y, Schramm G, Kimmig D, Knoss S, Weyergraf A, Kapp A, Elsner J (2001) Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. J Invest Dermatol 116: 498–505PubMedCrossRefGoogle Scholar
  27. Elias PM, Wood LC, Feingold KR (1999) Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 10: 119–126PubMedCrossRefGoogle Scholar
  28. Elliot K, Forrest S (2002) Genetics of atopic dermatitis. In: Bieber T, Leung DYM (eds) Atopic dermatitis. Marcel Dekker, New York, pp 81–110CrossRefGoogle Scholar
  29. Engelhardt E, Toksoy A, Goebeler M, Debus S, Bröcker E-B, Gillitzer R (1998) Chemokines IL-8, Gro-a, MCP-1, IP-10, and MIG are sequentially and differentially expressed during phase-specific infiltration of leukocyte subset in human wound healing. Am J Pathol 153: 1849–1860PubMedCrossRefGoogle Scholar
  30. Federici M, Giustizieri ML, Scarponi C, Girolomoni G, Albanesi C (2002) Impaired IFN-y-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J Immunol 169: 434–442PubMedGoogle Scholar
  31. Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Kar-pus WJ (2001) CXCL10 (IFN-y-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617–7624PubMedGoogle Scholar
  32. Fitzhugh DJ, Naik S, Caughman SW, Hwang ST (2000) C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro. J Immunol 165: 6677–6681PubMedGoogle Scholar
  33. Flier J, Boorsma DM, Bruynzeel DP, van Beek PJ, Stoof TJ, Scheper RJ, Willemze R, Tensen CP (1999) The CXCR3 activating chemokines íP10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol 113: 574–578PubMedCrossRefGoogle Scholar
  34. Förster R, Schubel A, Breitfeld D, Kremmer E, Renner-Müller I, Wolf E, Lipp M (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23–33PubMedCrossRefGoogle Scholar
  35. Fraticelli P, Sironi M, Bianchi G, D’Ambrosio D, Albanesi C, Stopacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A (2001) Fractalkine (CX3CL1) as an amplification circuit of polarized Thl responses. J Clin Invest 107: 1173–1181PubMedCrossRefGoogle Scholar
  36. Frezzolini A, Paradisi M, Zaffiro A, Provini A, Cadoni S, Ruffelli M, De Pita 0 (2002) Circulating interleukin 16 (IL-16) in children with atopic/ eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. Allergy 57: 815–820PubMedCrossRefGoogle Scholar
  37. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, Gray PW, Chantry D, Suzuki R, Yoshie O., (2002) Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 110: 139–146PubMedCrossRefGoogle Scholar
  38. Gillitzer R, Wolff K, Tong D, Müller C, Yoshimura T, Hartmann AA, Stingl G, Berger R (1993) MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101: 127–131PubMedCrossRefGoogle Scholar
  39. Girolomoni G, Sebastiani S, Albanesi C, Cavani A (2001) T-cell subpopulations in the development of atopic and contact allergy. Curr Opin Immunol 13: 733–737PubMedCrossRefGoogle Scholar
  40. Girolomoni G, Pastore S (2001) Epithelial cells and atopic diseases. Curr Allergy Asthma Rep 1: 481–482PubMedCrossRefGoogle Scholar
  41. Giustizieri ML, Albanesi C, Scarponi C, De Pità O, Girolomoni G (2002) Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo. Am J Pathol 161: 1409–1418PubMedCrossRefGoogle Scholar
  42. Giustizieri ML, Mascia F, Frezzolini A, De Pità O, Chinni ML, Giannetti A, Girolomoni G, Pastore S (2001) Keratinocytes from patients with atopic dermatitis and psoriasis show a different chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 107: 871–877PubMedCrossRefGoogle Scholar
  43. Goebeler M, Trautmann A, Voss A, Bröcker E-B, Toksoy A, Gillitzer R (2001) Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol 158: 431–440PubMedCrossRefGoogle Scholar
  44. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, Martinez AC, Dorf M, Bjerke T, Coyle AJ, Gutierrez-Ramos JC (1998) The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 188: 157–167PubMedCrossRefGoogle Scholar
  45. Gottlieb AB, Luster AD, Posnett DN, Carter DM (1998) Detection of a y interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 168: 941–948CrossRefGoogle Scholar
  46. Griffiths CEM, Barker JN, Kunkel S, Nickoloff BJ (1991) Modulation of leukocyte adhesion molecule, a T-cell chemotaxin (IL-8) and a regulatory cytokine ( TNFa) in allergic contact dermatitis (rhus dermatitis ). Br J Dermatol 124: 519–531.Google Scholar
  47. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95: 258–263PubMedCrossRefGoogle Scholar
  48. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsukawa A, Williams LT, Nakano H (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189: 451–460PubMedCrossRefGoogle Scholar
  49. Haase I, Hobbs RM, Romero MR, Broad S, Watt FM (2001) A role for mitogen-activated protein-kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108: 527–536PubMedGoogle Scholar
  50. Homey B, Dieu-Nosejan M-C, Wiesenborn A, Massacrier C, Pin J-J, Oldham E, Catron D, Buchanan ME, Müller A, deWaal Malefyt R, Deng G, Orozco R, Ruzicka T, Lehman P, Lebecque S, Caux C, Zlotnik A (2000a) Upregulation of macrophage inflammatory protein 3a/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164: 6621–6632PubMedGoogle Scholar
  51. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Muller A, McClanahan TK, Dieu-Nosjean MC, Orozco R, Ruzicka T, Lehmann P, Oldham E, Zlotnik A ( 2000 b) The orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 ( CTACK/ALP/ILC ). J Immunol 164: 3465–3470Google Scholar
  52. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bunemann E, Lehto M, Wolff H, Yen D, Marx-hausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A (2002) CCL27–CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8: 157–165PubMedCrossRefGoogle Scholar
  53. Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T, Harada S, Fukunaga A, Chantry D, Gray PW, Morita A, Suzuki R, Tezuka T, Ichihashi M, Yoshie 0 (2002) IFN-y-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 14: 767–773Google Scholar
  54. Hudak S, Hagen M, Liu Y, Catron D, Oldham E, McEvoy LM, Bowman EP (2002) Immune surveillance and effector functions of CCR10+ skin homing T cells. J Immunol 169: 1189–1196PubMedGoogle Scholar
  55. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D’Ambrosio D (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J Exp Med 194: 847–853PubMedCrossRefGoogle Scholar
  56. Johnson CD, Kingsnorth AN, Imne CW, McMahon MJ, Neoptolemos JP, McKay C, Toh SK, Skaife P, Leeder PC, Wilson P, Larvin M, Curtis LD (2001) Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 48: 62–69PubMedCrossRefGoogle Scholar
  57. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S (2001) Enhanced production of CC-chemokines (RANTES, MCP-1, MIP1a, MIP-1ß, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293: 350–355PubMedCrossRefGoogle Scholar
  58. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Komine M, Asahina A, Tamaki K (2002) Serum macrophage-derived chemokine ( MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 27: 270–273Google Scholar
  59. Karvonen SL, Korkiamaki T, Yla-Outinen H, Nissinen M, Teerikangas H, Pummi K, Karvonen J, Peltonen J (2000) Psoriasis and altered calcium metabolism: downregulated capacitative calcium influx and defective calcium-mediated cell signaling in cultured psoriatic keratinocytes. J Invest Dermatol 114: 693–700PubMedCrossRefGoogle Scholar
  60. Kaser A, Dunzendorfer S, Offner FA, Ryan T, Schwabegger A, Cruikshank WW, Wiedermann CJ, Tilg H (1999) A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol 163: 3232–3238PubMedGoogle Scholar
  61. Kehren J, Desvignes C, Krasteva M, Ducluzeau M-T, Assossou O, Horand F, Hahne M, Kägi D, Kaiserlian D, Nicolas J-F (1999) Cytotoxicity is mandatory for CD8+ T cell-mediated contact hypersensitivity. J Exp Med 189: 779–786PubMedCrossRefGoogle Scholar
  62. Koelle DM, Liu Z, McClurkan CM, Topp MS, Riddell SR, Pamer EG, Johnson AS, Wald A, Corey L (2002) Expression of cutaneous lymphocyte-associated antigen by CD8+ T cells specific for a skin-tropic virus. J Clin Invest 110: 537–548PubMedGoogle Scholar
  63. Kozma GT, Falus A, Bojszko A, Krikovszky D, Szabo T, Nagy A, Szalai C (2002) Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1. Allergy 57: 160–163PubMedCrossRefGoogle Scholar
  64. Kraft S, Novak N, Katoh N, Bieber T, Rupec RA (2002) Aggregation of the high-affinity IgE receptor FcaRI on human monocytes and dendritic cells induces NF-KB activation. J Invest Dermatol 118: 830–837PubMedCrossRefGoogle Scholar
  65. Krueger JG (2002) The immunologic basis for the treatment of psoriasis with new biological agents. J Am Acad Dermatol 46: 1–23PubMedCrossRefGoogle Scholar
  66. Kulke R, Bornscheuer E, Schluter C, Bartels J, Rowert J, Sticherling M, Christophers E (1998) The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol 110: 90–94PubMedCrossRefGoogle Scholar
  67. Kunkel EJ, Butcher EC (2002) Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1–4PubMedCrossRefGoogle Scholar
  68. Laberge S, Ghaffar O, Boguniewicz M, Center DM, Leung DY, Hamid Q (1998) Association of increased CD4+ T-cell infiltration with increased IL-16 expression in atopic dermatitis. J Allergy Clin Immunol 102: 645–650CrossRefGoogle Scholar
  69. la Sala A, Sebastiani S, Ferrari D, Di Virgilio F, Izdko M, Norgauer J, Girolomoni G (2002) Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood 99: 1715–1722CrossRefGoogle Scholar
  70. Leung DY, Soter NA (2001) Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol 44: S1 — S12PubMedCrossRefGoogle Scholar
  71. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. (1999) CC-chemokine receptor 6 is expressed in diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3a. J Immunol 162: 186–194PubMedGoogle Scholar
  72. Loetscher P, Pellegrino A, Gong J-H, Mattioli, I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I (2001) The ligands of CXC receptor 3, I-TAC, Mig, and IP-10 are natural antagonists for CCR3. J Biol Chem 276: 2986–2991PubMedCrossRefGoogle Scholar
  73. Luster AD (2002) The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 14: 129–135PubMedCrossRefGoogle Scholar
  74. Luther SA, Cyster JG (2001) Chemokines as regulators of T cell differentiation. Nat Immunol 2: 102–107PubMedCrossRefGoogle Scholar
  75. Mackay CR (2001) Chemokines: immunology’s high impact factors. Nat Immunol 2: 95–101PubMedCrossRefGoogle Scholar
  76. Mascia F, Mariani V, Giannetti A, Girolomoni G, Pastore S (2002) House dust mite allergen exerts no direct proinflammatory effects on human keratinocytes. J Allergy Clin Immunol 109: 532–538PubMedCrossRefGoogle Scholar
  77. Mekory YA, Metcalfe DD. (1999) Mast cell-T cell interactions. J Allergy Clin Immunol 104: 517–523CrossRefGoogle Scholar
  78. Mellado M, Rodriguez-Frade JM, Manes S, Martinez-A C (2001) Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19: 397–421Google Scholar
  79. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schröder JE (1998) IL-4 induces eotaxin: a possible mechanism of selective eosinophils recruitment in helminth infection and atopy. J Immunol 160: 60–68PubMedGoogle Scholar
  80. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, Orozco R, Copeland NG, Jenkins NA, McEvoy LM, Zlotnik A (1999) CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 96: 14470–14475PubMedCrossRefGoogle Scholar
  81. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2: 123–128PubMedCrossRefGoogle Scholar
  82. Nakamura K, Williams IR, Kupper TS (1995) Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 105: 635–643PubMedCrossRefGoogle Scholar
  83. Nakatani T, Kaburagi Y, Shimada Y, Inaoki M, Takehara K, Mukaida N, Sato S (2001) CCR4+ memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 107: 353–358PubMedCrossRefGoogle Scholar
  84. Nakayama N, Fujisawa R, Yamada H, Horikawa T, Kawasaki H, Hieshima K, Izawa D, Fujiie S, Tezuka T, Yoshie 0 (2000) Inducible expression of a CC chemokine liver-and activation-regulated chemokine (LARC)/ macrophage inflammatory protein (MIP)-3a/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 13: 95–103Google Scholar
  85. Nickel RG, Casolaro V, Wahn U, Beyer K, Barnes KC, Plunkett BS, Freidhoff LR, Sengler C, Plitt JR, Schleimer RP Caraballo L, Naidu RP, Levett PN, Beaty TH, Huang SK (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164: 1612–1616.PubMedGoogle Scholar
  86. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ (1994) Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 144: 820–828PubMedGoogle Scholar
  87. Nickoloff BJ, Schröder JM, von den Driesch P, Raychaudhuri SP, Farber EM, Boehncke WH, Morhenn VB, Rosenberg EW, Schön MP, Holick MF (2000) Is psoriasis a T-cell disease? Exp Dermatol 9: 359–375PubMedCrossRefGoogle Scholar
  88. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M (2001) Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5 Blood 97: 1920–1924Google Scholar
  89. Okazaki H, Kakurai M, Hirata D, Sato H, Kamimura T, Onai N, Matsushima K, Nakagawa H, Kano S, Minota S (2002) Characterization of chemokine receptor expression and cytokine production in circulating CD4+ T cells from patients with atopic dermatitis: upregulation of C-C chemokine receptor 4 in atopic dermatitis. Clin Exp Allergy 32: 1236–1242PubMedCrossRefGoogle Scholar
  90. Ormerod AD, Weller R, Copeland P, Benjamin N, Ralston SH, Grabowksi P, Herriot R (1998) Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res 290: 3–8PubMedCrossRefGoogle Scholar
  91. Pastore S, Fanales-Belasio E, Albanesi C, Chinni ML, Giannetti A, Girolomoni G (1997) Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 99: 3009–3017Google Scholar
  92. Pastore S, Giustizieri M, Mascia F, Giannetti A, Kaushansky K, Girolomoni G (2000) Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/ macrophage-colony stimulating factor. J Invest Dermatol 115: 1134–1143PubMedCrossRefGoogle Scholar
  93. Petering H, Höchstetter R, Kimming D, Smolarski R, Kapp A, Elsner J (1998) Detection of MCP-4 in dermal fibroblast and its activation of the respiratory burst inhuman eosinophils. J Immunol 160: 555–558PubMedGoogle Scholar
  94. Reich K, Garbe C, Blaschke V, Maurer C, Middel P, Westphal G, Lippert U, Neumann C (2001 a) Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation. J Invest Dermatol 116: 319–329Google Scholar
  95. Reich K, Heine A, Hugo S, Blaschke V, Middel P, Kaser A, Tilg H, Blaschke S, Gutgesell C, Neumann C (2001 b) Engagement of FceRI stimulates the production of IL-16 in Langerhans cell-like dendritic cells. J Immunol 167: 6321–6329Google Scholar
  96. Reich K, Hugo S, Middel P, Blaschke V, Heine A, Gutgesell C, Williams R, Neumann C (2002) Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitis. J Allergy Clin Immunol 109: 681–687PubMedCrossRefGoogle Scholar
  97. Rennert PD, Hochman PS, Flavell RA, Chaplin DD, Jayaraman S, Browning JL, Fu Y-X (2001) Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-a-deficient mice. J Exp Med 193: 1227–1238PubMedCrossRefGoogle Scholar
  98. Robert C, Kupper TS (1999) Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 341: 1817–1828Google Scholar
  99. Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18: 217–242PubMedCrossRefGoogle Scholar
  100. Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG (2001) Potential role of the chemokine receptors CXCR3, CCR4, and the integrin aEß7 in the pathogenesis of psoriasis vulgaris. Lab Invest 8: 335–347CrossRefGoogle Scholar
  101. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, Forster R, Lipp M, Lanzavecchia A (1999 a) Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 29: 2037–2045Google Scholar
  102. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999b) Two subsets of memory T lymphocytes with distinct homing potential and effector function. Nature 401: 708–712PubMedCrossRefGoogle Scholar
  103. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, Forster R, Brugstahler R, Lipp M, Lanzavecchia A (1999c) Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29: 1617–1625PubMedCrossRefGoogle Scholar
  104. Sallusto F, Mackay CF, Lanzavecchia A (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Inununol 18: 593–620CrossRefGoogle Scholar
  105. Salomon I, Netzer N, Wildbaum G, Schif-Zuck S, Maor G, Karin N (2002) Targeting the function of IFN-y-inducible Protein 10 suppresses ongoing adjuvant arthritis. J Immunol 169: 2685–2693PubMedGoogle Scholar
  106. Schmuth M, Neyer S, Rainer C, Grassegger A, Fritsch P, Romani N, Heufler C (2002) Expression of the C-C chemokine MIP-3a/CCL20 in human epidermis with impaired permeability barrier function. Exp Dermatol 11: 135–142PubMedCrossRefGoogle Scholar
  107. Schön MP, Ruzicka T (2001) Psoriasis: the plot thickens Nat Immunol 2: 91CrossRefGoogle Scholar
  108. Schröder JM, Mochizuki M (1999) The role of chemokines in cutaneous allergic inflammation. Biol Chem 389: 889–896Google Scholar
  109. Schwarz A, Beissert S, Grosse-Heitmeyer K, Gunzer M, Bluestone JA, Grabbe S, Schwarz T (2000) Evidence for functional relevance of CTLA4 in ultraviolet-radiation-induced tolerance. J Immunol 165: 1824–1831PubMedGoogle Scholar
  110. Sebastiani S, Allavena P, Albanesi C, Nasorri F, Bianchi G, Traidl C, Sozza-ni S, Girolomoni G, Cavani A (2001) Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 116: 996–1002Google Scholar
  111. Sebastiani S, Albanesi C, Nasorri F, Girolomoni G, Cavani A (2002) Nickel-specific CD8+ and CD4+ T cells display distinct migratory response to chemokines produced during allergic contact dermatitis. J Invest Dermatol 118: 1052–1058PubMedCrossRefGoogle Scholar
  112. Sirsjo A, Karlsson M, Gidlof A, Rollman O, Torma H (1996) Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 134: 643–648PubMedCrossRefGoogle Scholar
  113. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ (2002) Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol 3: 673–680Google Scholar
  114. Sozzani S, Allavena P, Vecchi A, Mantovani A (2000) Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Clin Immunol 20: 151–160PubMedCrossRefGoogle Scholar
  115. Stingl G, Maurer D (1997) IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells. Int Arch Allergy Immunol 113: 24–29PubMedCrossRefGoogle Scholar
  116. Stoof TJ, Flier J, Sampat S, Nieboer C, Tensen CP, Boorsma DM (2001) The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br J Dermatol 144: 1114–1120PubMedCrossRefGoogle Scholar
  117. Taha RA, Minshall EM, Leung DY, Boguniewicz M, Luster A, Muro S, Toda M, Hamid QA (2000) Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol 105: 1002–1007PubMedCrossRefGoogle Scholar
  118. Traidl C, Sebastiani S, Albanesi C, Merk HF, Puddu P, Girolomoni G, Cava-ni A (2000) Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. J Immunol 165: 3058–3064PubMedGoogle Scholar
  119. Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon HU, Graeve T, Noll M, Brocker EB, Blaser K, Akdis CA (2000) T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 106: 25–35PubMedCrossRefGoogle Scholar
  120. Tsuji RI, Kawikova I, Ramabhadran R, Akahira-Azuma M, Taub D, Hugli T, Gerard C, Askenase PW (2000) Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol 165: 1588–1598PubMedGoogle Scholar
  121. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, Rao P, Ponath PD, Baggiolini M, Dahinden CA (1997) High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100: 1137–1143PubMedCrossRefGoogle Scholar
  122. Vanbervliet B, Homey B, Durand I, Massacrier C, Ait-Yahia S, de Bouteiller O, Vicari A, Caux C (2002) Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur J Immunol 32: 231–242PubMedCrossRefGoogle Scholar
  123. Varona R, Villares R, Carramolino L, Goya I, Zaballos A, Gutierréz J, Torres M, Martinez-A C, Màrquez G (2001) CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J Clin Invest 107: R37 - R45Google Scholar
  124. Vestergaard C, Bang K, Gesser B, Yoneymana H, Matsushima K, Larsen CG (2000) A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 115: 640–646PubMedCrossRefGoogle Scholar
  125. Vissers JLM, Hartgers FC, Lindhout E, Teunnisen MBM, Figdor CG, Ade-ma GJ (2001) Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J Leukoc Biol 69: 785–793PubMedGoogle Scholar
  126. von Andrian UH, Mackay CR (2000) T-cell function and migration. Two sides of the same coin. N Engl J Med 343: 1020–1034.Google Scholar
  127. von Bubnoff D, Geiger E, Bieber T (2001) Antigen-presenting cells in allergy. J Allergy Clin Immunol 108: 329–339CrossRefGoogle Scholar
  128. Vulcano M, Albanesi C, Stopacciaro A, Bagnati R, D’Amico G, Struyf S, Transidico P, Bonecchi R, Del Prete A, Allavena P, Ruco LP, Chiabrando C, Girolomoni G, Mantovani A, Sozzani S (2001) Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 31: 812–822PubMedCrossRefGoogle Scholar
  129. Wakugawa M, Nakamura K, Kakinuma T, Onai N, Matsushima K, Tamaki K (2001) CC chemokine receptor 4 expression on peripheral blood CDC T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 117: 188–196PubMedCrossRefGoogle Scholar
  130. Wang B, Fujisawa H, Zhuang L, Freed I, Howell BG, Shahid S, Shivji GM, Mak TW, Sauder DN (2000) CD4+ Thl and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 165: 6783–6790PubMedGoogle Scholar
  131. Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA (1998) Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 273: 18288–18291PubMedCrossRefGoogle Scholar
  132. Yamamoto J, Adachi Y, Onoue Y, Adachi YS, Okabe Y, Itazawa T, Toyoda M, Seki T, Morohashi M, Matsushima K, Miyawaki T (2000) Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells. J Leukoc Biol 68: 568–574PubMedGoogle Scholar
  133. Yasukawa H, Sasaki A, Yoshimura A (2000) Negative regulation of cytokine signaling. Annu Rev Immunol 18: 143–164PubMedCrossRefGoogle Scholar
  134. Yawalkar N, Uguccioni M, Scharer J, Braunwalder J, Karlen S, Dewald B, Braathen LR, Baggiolini M (1999) Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 113: 43–48PubMedCrossRefGoogle Scholar
  135. Yokozeki H, Ghoreishi M, Takagawa S, Takayama K, Satoh T, Katayama I, Takeda K, Akira S, Nishiota K (2000) Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 191: 995–1004PubMedCrossRefGoogle Scholar
  136. Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, Roberts AI, Ebert EC, Kassam N, Qin S, Zovko M, LaRosa GJ, Yang LL, Soler D, Butcher EC, Ponath PD, Parker CM, Andrew DP (1999) Human G protein-coupled receptor GPR9–6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med 190: 1241–1256PubMedCrossRefGoogle Scholar
  137. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12: 121–127Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • G. Girolomoni
  • S. Pastore
  • A. Cavani
  • C. Albanesi

There are no affiliations available

Personalised recommendations